Cohen Lawrence B Renovo Rx, Inc. Transaction History

Cohen Lawrence B

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.84 - $2.79 $79,200 - $120,092	43,044 Added 79.53%	97,165 $196,000
Q3 2022 Nov 09, 2022	SELL	$1.84 - $2.79 $79,200 - $120,092	-43,044 Reduced 44.3%	54,121 $159,000
Q2 2022 Aug 11, 2022	BUY	$1.52 - $2.99 $65,426 - $128,701	43,044 Added 79.53%	97,165 $192,000
Q1 2022 May 13, 2022	BUY	$2.87 - $4.9 $155,327 - $265,192	54,121 New	54,121 $159,000

1.87M

Ticker RNXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,066,860
Market Cap $9.25M
Description
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...

Get notified when there are updates to the investment portfolio of Cohen Lawrence B, based on Form 13F filings with the SEC.

Stay updated on Cohen Lawrence B with notifications on news.